Target Name: DUT
NCBI ID: G1854
Review Report on DUT Target / Biomarker Content of Review Report on DUT Target / Biomarker
DUT
Other Name(s): Deoxyuridine 5-triphosphate nucleotidohydrolase, mitochondrial | Deoxyuridine-triphosphatase | Deoxyuridine triphosphatase, transcript variant 1 | dUTP nucleotidohydrolase | BMFDMS | deoxyuridine trip

DUT: A Promising Drug Target / Biomarker

Drug targets (DUs) are proteins that are targeted by drugs to inhibit their activity or prevent their formation, which can lead to the treatment of various diseases. Discovering new DUs is a critical step in the development of new therapeutics. In this article, we will discuss DUT, a drug target that has gained significant attention in recent years due to its potential in treating various diseases.

DUT Background

DUTs, also known as de novo transmembrane proteins, are newly synthesized proteins that are introduced into the cell membrane. These proteins play a crucial role in various physiological processes in the cell, including signaling, transport, and structure. DUTs are usually involved in cell signaling pathways and are involved in many different signaling pathways.

One of the most significant functions of DUTs is their role in intracellular signaling. DUTs can interact with various signaling molecules, including tyrosine kinases, G-protein-coupled receptors, and ion channels, to regulate cellular signaling pathways. DUTs can also play a role in regulating the cytoskeleton, which is essential for cell structure and movement.

DUTs have also been shown to play a key role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, DUTs have been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, through their role in the regulation of the cytoskeleton and the formation of neurofibrillary tangles.

DUTs are also being targeted by researchers for their potential use as drug targets. The development of new therapeutics that target DUTs has the potential to treat a wide range of diseases. Some of the most promising DUT targets include those associated with cancer, neurodegenerative diseases, and autoimmune diseases.

Exercise and DUTs

DUTs are involved in many of the physiological processes that are essential for exercise, including muscle contractions and oxygen transportation. For example, DUTs are involved in the regulation of muscle protein synthesis and the formation of myofibrils, which are the building blocks of muscle tissue. DUTs are also involved in the regulation of oxygen transportation, which is essential for maintaining muscle oxygen supply during exercise.

DUTs have also been shown to play a key role in the regulation of inflammation and pain. DUTs are involved in the regulation of the immune response and the production of pro-inflammatory cytokines, which contribute to inflammation. DUTs have also been shown to play a key role in the regulation of pain perception and the production of pain hormones.

DUTs and Cancer

DUTs have been shown to play a key role in the development and progression of cancer. DUTs are involved in the regulation of cell signaling pathways, including those that promote the growth and survival of cancer cells. DUTs have also been shown to play a key role in the regulation of cell division, which is essential for the growth and proliferation of cancer cells.

DUTs have also been shown to contribute to the development of neurocancer, which is a type of cancer that affects the nervous system. DUTs are involved in the regulation of neuroplasticity, which is the ability of the nervous system to adapt and reorganize itself in response to environmental stimuli. DUTs have also been shown to play a key role in the regulation of neurogenesis, which is the process by which new neurons are produced in the nervous system.

DUTs and Neurodegenerative Diseases

DUTs have also been shown to play a key role in the development and progression of neurodegenerative diseases, which are conditions that affect the nervous system and are characterized by progressive loss of brain cells. DUTs are involved in the regulation of

Protein Name: Deoxyuridine Triphosphatase

Functions: Catalyzes the cleavage of 2'-deoxyuridine 5'-triphosphate (dUTP) into 2'-deoxyuridine 5'-monophosphate (dUMP) and inorganic pyrophosphate and through its action efficiently prevents uracil misincorporation into DNA and at the same time provides dUMP, the substrate for de novo thymidylate biosynthesis (PubMed:17880943, PubMed:8631816, PubMed:8805593). Inhibits peroxisome proliferator-activated receptor (PPAR) activity by binding of its N-terminal to PPAR, preventing the latter's dimerization with retinoid X receptor (By similarity). Essential for embryonic development (By similarity)

The "DUT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DUTP6 | DUX1 | DUX3 | DUX4 | DUX4L1 | DUX4L13 | DUX4L16 | DUX4L18 | DUX4L19 | DUX4L2 | DUX4L20 | DUX4L23 | DUX4L3 | DUX4L37 | DUX4L4 | DUX4L5 | DUX4L6 | DUX4L7 | DUX4L8 | DUX4L9 | DUXA | DUXAP10 | DUXAP3 | DUXAP8 | DUXAP9 | DVL1 | DVL2 | DVL3 | DXO | DYDC1 | DYDC2 | DYM | Dynactin | DYNAP | DYNC1H1 | DYNC1I1 | DYNC1I2 | DYNC1LI1 | DYNC1LI2 | DYNC2H1 | DYNC2I1 | DYNC2I2 | DYNC2LI1 | DYNLL1 | DYNLL2 | DYNLRB1 | DYNLRB2 | DYNLRB2-AS1 | DYNLT1 | DYNLT2 | DYNLT2B | DYNLT3 | DYNLT4 | DYNLT5 | DYRK1A | DYRK1B | DYRK2 | DYRK3 | DYRK4 | DYSF | Dystrophin-Associated Glycoprotein Complex | DYTN | DZANK1 | DZIP1 | DZIP1L | DZIP3 | E2F Transcription Factor | E2F-6 complex | E2F1 | E2F2 | E2F3 | E2F4 | E2F5 | E2F6 | E2F6P4 | E2F7 | E2F8 | E3 ubiquitin-protein ligase | E4F1 | EAF1 | EAF2 | EAPP | Early growth response | EARS2 | EBAG9 | EBF1 | EBF2 | EBF3 | EBF4 | EBI3 | EBLN1 | EBLN2 | EBLN3P | EBNA1BP2 | EBP | EBPL | ECD | ECE1 | ECE1-AS1 | ECE2